<DOC>
	<DOCNO>NCT02389803</DOCNO>
	<brief_summary>Study design : Double blind , randomize , placebo control study . Participants randomly assign either intervention group placebo control group . Randomization two study group make ratio 1:1 . The primary objective study assess effect 6-12 month treatment nutritional supplementation standardize formula , short lean boy adolescent weight Standard Deviation Score ( SDS ) height SDS The Secondary Objectives study assess effect 6-12 month treatment nutritional supplementation standardize formula , short lean boy adolescent BMI SDS , growth velocity , time puberty , quality life self-esteem The study continue 6 month intervention versus active placebo , additional optional 6 month ( extension period ) , participant group , intervention placebo , offer continue participation study study supplement . All analyse effect 's primary secondary outcome measurement take account consumption rate study formula/placebo</brief_summary>
	<brief_title>Evaluating Effect Nutritional Supplementation Growth Short Lean Adolescents Boys</brief_title>
	<detailed_description />
	<mesh_term>Dwarfism</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<criteria>Boys age ≥10years old Prepubertal Tanner stage 1 ( gonadarche ) ( testicular volume &lt; 4 ) Height weight ≤ 10th percentile age gender . HeightSDS ≥ 2.5 SDS BMISDS &gt; 3 SDS Low proportion weight height Signing inform consent form Diagnosis Growth Hormone ( GH ) Deficiency treatment GH Any know chronic disease dysmorphic syndrome include : bone disease , organic brain disease , neurological disease , past current malignancy , chronic cardiac , renal pulmonary problem Any know gastrointestinal disease include malabsorption Any known organic reason growth retardation</criteria>
	<gender>Male</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>